Volume 21, Number 6—June 2015
Dispatch
Acute Middle East Respiratory Syndrome Coronavirus Infection in Livestock Dromedaries, Dubai, 2014
Sung Sup Park, Ulrich Wernery
, Victor M. Corman, Emily Y.M. Wong, Alan K.L. Tsang, Doreen Muth, Susanna K. P. Lau, Kamal Khazanehdari, Florian Zirkel, Mansoor Ali, Peter Nagy, Jutka Juhasz, Renate Wernery, Sunitha Joseph, Ginu Syriac, Shyna K. Elizabeth, Nissy Annie Georgy Patteril, Patrick C. Y. Woo, and Christian Drosten
, Victor M. Corman, Emily Y.M. Wong, Alan K.L. Tsang, Doreen Muth, Susanna K. P. Lau, Kamal Khazanehdari, Florian Zirkel, Mansoor Ali, Peter Nagy, Jutka Juhasz, Renate Wernery, Sunitha Joseph, Ginu Syriac, Shyna K. Elizabeth, Nissy Annie Georgy Patteril, Patrick C. Y. Woo, and Christian Drosten
Table 2
Results of testing for the presence of MERS-CoV and MERS-CoV antibody in 15 mother–calf pairs in a dromedary breeding flock, Dubai, May 2014*
| Camel |
Antibody ELISA | Virus isolation | PCR, threshold cycle | |||||
|---|---|---|---|---|---|---|---|---|
| Day 0 |
Day 8 |
Day 0 |
Day 8 |
Day 0 |
Day 8 |
|||
| Mother | ||||||||
| M1 | + | ND | − | ND | − | ND | ||
| M2 | + | ND | − | ND | − | ND | ||
| M3 | + | ND | − | ND | − | ND | ||
| M4 | + | ND | − | ND | − | ND | ||
| M5 | + | ND | − | ND | − | ND | ||
| M6 | + | ND | − | ND | − | ND | ||
| M7 | + | ND | − | ND | − | ND | ||
| M8 | + | ND | − | ND | − | ND | ||
| M9 | + | ND | − | ND | − | ND | ||
| M10 | + | ND | − | ND | − | ND | ||
| M11 | + | ND | − | ND | − | ND | ||
| M12 | + | ND | − | ND | − | ND | ||
| M13 | + | ND | − | ND | − | ND | ||
| M14 | + | ND | − | ND | − | ND | ||
| M15 | + | ND | − | ND | − | ND | ||
| Total |
15 |
NA |
0 |
NA |
0 |
NA |
||
| Calf | ||||||||
| C1 | ± | + | + | − | 19.5 | − | ||
| C2 | + | + | − | − | − | − | ||
| C3 | + | + | − | − | 24.3 | − | ||
| C4 | − | + | − | − | 26.8 | 32.3 | ||
| C5 | ± | + | − | − | 30.4 | − | ||
| C6 | − | + | − | − | 26.5 | − | ||
| C7 | + | + | − | − | − | − | ||
| C8 | + | + | − | − | − | − | ||
| C9 | + | + | + | − | 23.8 | − | ||
| C10 | + | + | + | − | 24.1 | − | ||
| C11 | + | + | + | − | 22.3 | 34.2 | ||
| C12 | + | + | − | − | − | − | ||
| C13 | + | + | − | − | 22.8 | 34.2 | ||
| C14 | + | + | + | − | 20.7 | − | ||
| C15 | + | + | − | − | 32.4 | 35.3 | ||
| Total | 11 (+2) | 15 | 5 | 0 | 11 | 4 | ||
*MERS-CoV, Middle East respiratory syndrome coronavirus; NA, not applicable ND, not done; +, positive; −, negative; ±, weak positive (borderline optical density range as identified by the reagent manufacturer, EUROIMMUN, Lübeck, Germany).
Page created: May 15, 2015
Page updated: May 15, 2015
Page reviewed: May 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.